Back to Search
KATHERINE WEILBAECHER, MD
MD
Medical Oncology Physician
NPI: 1447277942IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
2000166707(MO)
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1992
Research & Publications (20)
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts.
PMID 19442620·Bone·2009
7-preclinical
Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases.
PMID 19059914·J Biol Chem·2009
7-preclinical
Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.
PMID 18927277·Clin Cancer Res·2008
6-review
Multiple facets of junD gene expression are atypical among AP-1 family members.
PMID 18427548·Oncogene·2008
6-review
RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation.
PMID 18322009·Proc Natl Acad Sci U S A·2008
7-preclinical
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.
PMID 18260128·J Cell Biochem·2008
7-preclinical
A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.
PMID 18070929·Mol Cell Biol·2008
7-preclinical
Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients.
PMID 17785550·Clin Cancer Res·2007
8-other
Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone.
PMID 17715292·Proc Natl Acad Sci U S A·2007
7-preclinical
Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide.
PMID 17268030·J Nucl Med·2007
7-preclinical
Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner.
PMID 17192391·Blood·2007
7-preclinical
Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference.
PMID 17062702·Clin Cancer Res·2006
8-other
MRI detection of early bone metastases in b16 mouse melanoma models.
PMID 16283483·Clin Exp Metastasis·2005
7-preclinical
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.
PMID 16118323·Blood·2005
7-preclinical
Platelet and osteoclast beta3 integrins are critical for bone metastasis.
PMID 14612570·Proc Natl Acad Sci U S A·2003
7-preclinical
Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
PMID 12472287·Am J Clin Pathol·2002
4-observational
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.
PMID 11929831·Cancer Res·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4921 PARKVIEW PL, DIV IM MEDICAL ONCOLOGY, STE 7A, 7B, 7C
SAINT LOUIS, MO 63110 - Phone
- (800) 647-2098
Quick Facts
- NPI
- 1447277942
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile